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A commentary on
Estrogenic and anti-androgenic endocrine disrupting chemicals and their impact on the male
reproductive system
by De Falco M, Forte M, Laforgia V. Front Environ Sci (2015) 3:3. doi: 10.3389/fenvs.2015.00003
During the last two decades or so, endocrine-disrupting chemicals (EDCs) and their effects on
human health have become one of the most researched and controversial topics in toxicology. There
are a number of reviews on the health consequences of exposure to EDCs including a comprehensive
report by the World Health Organization and the United Nations Environment Programme (1).
Recently, De Falco et al. (2) addressed the impact of EDCs onmale reproductive system, with special
reference to the effects of bisphenol A (BPA), alkylphenols, and phthalates. Jeng (3) also reviewed the
epidemiological data on the adverse effects of EDCs onmale reproduction and experimental studies
that could shed light on mechanisms (disruption of steroidogenesis, oxidative stress, and epigenetic
changes) through which EDCs could impair male reproductive health. Both articles are essentially
narrative reviews of the abundant and highly controversial literature on the health consequences of
exposures to EDCs.
A key feature that distinguishes a narrative review from a systematic review is that the former
review does not include a comprehensive and meticulous search of all potentially relevant articles
on specified sources, and does not use explicit and reproducible criteria to selected articles for review
(4). Compared to systematic reviews, narrative reviews of the literature are more likely to error and
bias in the selection of relevant studies (4, 5). Moreover, if research designs, methods, and study
characteristics do not undergo a critical appraisal, summary, and conclusions of literature reviews
are even more prone to bias.
De Falco et al. were unable to convey to readers an unbiased review of the empirical evi-
dence suggesting that environmental exposures to EDCs might affect male reproduction. The
authors, for instance, did not disclose the conflicting evidence on the enlargement of prostate after
developmental exposure to BPA. In the mid-1990s, a set of studies by vom Saal and coworkers
showed that prenatal exposure to β-estradiol (EST), diethylstilbestrol (DES), or BPA led to enlarged
ventral prostate in adult mice (6, 7). The observation that enlargement of prostate resulted from
prenatal exposures to low doses of estrogenic compounds (e.g., supra-physiological levels of EST),
and exhibited non-monotonic dose–response relationships, fueled considerable debate over the
adverse health consequences of environmental exposure to EDCs. Several studies, however, failed
to reproduce these findings not only with BPA but also with EST and DES (8–10). Although
reproducibility is one hallmark of experimental sciences, the foregoing discrepancy between studies
by different authors has remained unexplained (11).
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Furthermore, authors’ statements that “: : :over 50 years, the
global average spermcountdroppedbyhalf: : :” and that “studiesof
the last decade strongly support that male reproductive health has
been deteriorating: : :” were unaccompanied by any reference to
the conflicting evidence on thismatter (2). Thewidespread notion
that semen quality has decreased over the past decades stands on
some retrospective studies [Ref. (12, 13), and others]. Nonetheless,
results fromanumberof other studies (not citedby the authors) are
inconsistentwith this hypothesis.Most studies showingdownward
trends in sperm counts included samples coming from different
populations and places that do not necessarily allow a valid com-
parison over time. For instance, a re-analysis of US data used
by Carlsen et al. (12) found no decline in sperm counts when
data from New York were excluded from the regression analysis
(14). Therefore, apparent time trend toward lower concentrations
reported by Carlsen et al. (12) resulted, in fact, from geographic
variations in sperm counts (14, 15).Moreover, a longitudinal study
of sperm concentrations for Danish military draftees (5000 men),
collected annually for 15 years (1996–2010), found no indication
that semenquality has changedduring themonitoring period (16).
Although several studies precipitated by reports on “downward
temporal trends in sperm counts” refuted its existence, the “sperm
crisis” notion is still a highly controversial issue in the literature
(17–20). Temporal trends to increasing birth prevalence of male
reproductive tract defects such hypospadias and cryptorchidism
described by some authors are far from being a consistent finding
among studies (21, 22).
The “endocrine disruptor hypothesis,” a landmark of which
was the Wingspread Conference Statement in 1990s (23), fits
like a glove to the beliefs of the public that pesticides and
other manmade chemicals in the environment are undermining
human health and fertility. Two seminal books by Rachel Carlson
(Silent Spring, 1962) and Theo Colborn (Our Stolen Future, 1996)
boosted considerably these concerns on the deleterious effects of
environmental chemicals on human fertility and health. Notwith-
standing the fact that ED hypothesis is instigating, the notion that
“male reproductive health has been deteriorating,” as asserted by
De Falco et al. (2) and others, lacks an unequivocal demonstration
by soundly designed epidemiology studies. It is of note that, even
if a temporal trend toward a worse male reproductive health
had been demonstrated consistently, it would still be missing to
prove that there is a causal link between EDCs, identified as such
in experimental tests, and the incidence of the adverse health
outcome in the human population. A step forward to identifying
relevant research gaps and to unveiling the real impact of EDCs
on male fertility and reproductive health would be to conduct
less and less narrative and potentially biased reviews and more
and more good quality systematic reviews of the literature on the
topic. Finally, we highlight that a critical appraisal of the quality
of original studies is required for both a good quality narrative
and a good quality systematic review. If unbiased, good quality
narrative reviews can also be helpful. Systematic reviews, however,
are a more reliable approach to avoid bias in the selection of
studies.
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